Cargando…

The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines

Nanoparticles (NPs) are intensively investigated as adjuvants in new generation vaccines, while how these NPs promote the immune responses has not been well understood. In this research, we have tried to elucidate the possible pathways for layered double hydroxide (LDH) NPs to provoke immune respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Shiyu, Xu, Kewei, Li, Li, Gu, Wenyi, Rolfe, Barbara E., Xu, Zhi P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158326/
https://www.ncbi.nlm.nih.gov/pubmed/30294273
http://dx.doi.org/10.3389/fphar.2018.01060
_version_ 1783358407357497344
author Yan, Shiyu
Xu, Kewei
Li, Li
Gu, Wenyi
Rolfe, Barbara E.
Xu, Zhi P.
author_facet Yan, Shiyu
Xu, Kewei
Li, Li
Gu, Wenyi
Rolfe, Barbara E.
Xu, Zhi P.
author_sort Yan, Shiyu
collection PubMed
description Nanoparticles (NPs) are intensively investigated as adjuvants in new generation vaccines, while how these NPs promote the immune responses has not been well understood. In this research, we have tried to elucidate the possible pathways for layered double hydroxide (LDH) NPs to provoke immune responses. As previously reported, LDH NPs efficiently deliver antigens to antigen presenting cells (APCs). In this research, we have found that these internalized LDH NPs are not released by these APCs within 8 h. We have for the first time found that macrophage cells exchange the internalized LDH NPs with other surrounding ones, which may promote immune responses in an additional way. Moreover, the internalized LDH-antigen NPs significantly facilitate the maturation of immature DCs and enhance cross-presentation of epitope/MHC class I complexes on the DC surface. This research would help understand the NP adjuvant mechanism and further assist the design of new specific NPs as more efficient nano-adjuvants.
format Online
Article
Text
id pubmed-6158326
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61583262018-10-05 The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines Yan, Shiyu Xu, Kewei Li, Li Gu, Wenyi Rolfe, Barbara E. Xu, Zhi P. Front Pharmacol Pharmacology Nanoparticles (NPs) are intensively investigated as adjuvants in new generation vaccines, while how these NPs promote the immune responses has not been well understood. In this research, we have tried to elucidate the possible pathways for layered double hydroxide (LDH) NPs to provoke immune responses. As previously reported, LDH NPs efficiently deliver antigens to antigen presenting cells (APCs). In this research, we have found that these internalized LDH NPs are not released by these APCs within 8 h. We have for the first time found that macrophage cells exchange the internalized LDH NPs with other surrounding ones, which may promote immune responses in an additional way. Moreover, the internalized LDH-antigen NPs significantly facilitate the maturation of immature DCs and enhance cross-presentation of epitope/MHC class I complexes on the DC surface. This research would help understand the NP adjuvant mechanism and further assist the design of new specific NPs as more efficient nano-adjuvants. Frontiers Media S.A. 2018-09-20 /pmc/articles/PMC6158326/ /pubmed/30294273 http://dx.doi.org/10.3389/fphar.2018.01060 Text en Copyright © 2018 Yan, Xu, Li, Gu, Rolfe and Xu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Yan, Shiyu
Xu, Kewei
Li, Li
Gu, Wenyi
Rolfe, Barbara E.
Xu, Zhi P.
The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines
title The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines
title_full The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines
title_fullStr The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines
title_full_unstemmed The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines
title_short The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines
title_sort pathways for layered double hydroxide nanoparticles to enhance antigen (cross)-presentation on immune cells as adjuvants for protein vaccines
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158326/
https://www.ncbi.nlm.nih.gov/pubmed/30294273
http://dx.doi.org/10.3389/fphar.2018.01060
work_keys_str_mv AT yanshiyu thepathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines
AT xukewei thepathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines
AT lili thepathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines
AT guwenyi thepathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines
AT rolfebarbarae thepathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines
AT xuzhip thepathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines
AT yanshiyu pathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines
AT xukewei pathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines
AT lili pathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines
AT guwenyi pathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines
AT rolfebarbarae pathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines
AT xuzhip pathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines